Skip to main content
QURE logo

uniQure N.V.

QURENASDAQHealthcareBiotechnology

$22.43Today:- (-)1Y −61.05%

As of Oct 23, 2026 close

Market cap
$1.49B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$8.73$71.50
Volume (live)
-
Avg. volume (3M)
2.90M

uniQure (QURE) Stock Price & Financial Analysis

uniQure Stock Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Price & Trading Activity
Day's Range$22.04 - $23.28
52-Week High$71.50
52-Week Low$8.73
Open$23.11
Volume (last close)884.42K
Average Volume (3M)2.90M
Earnings & Profitability
Revenue (TTM)18.67M
Net Income (TTM)-252.21M
Free Cash Flow (TTM)-161.01M
EPS (TTM)−$4.12
Profit Margin-1350.73%
Operating Margin-1061.06%
Return on Equity (ROE)-77.83%
Debt to Equity1.67
Dividend Information
Annual Dividend$0.00
Dividend Yield0.00%
Size & Valuation
Market Cap1.49B
Shares Outstanding66.24M
Price to Sales (P/S)79.58
Price to Book (P/B)4.59
EV/EBITDA-10.57
Technical Indicators
50-Day MA$38.35
200-Day MA$29.62
1-Year Change−61.05%

Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology

Compare QURE with other stocks

uniQure at a Glance

As of the Oct 23, 2026 close, uniQure (QURE) has a market capitalization of $1.49B. The stock trades at 79.6× sales. Over the trailing twelve months it lost $252.21M on revenue of $18.67M and burned $161.01M of free cash flow. Revenue grew 30.2% year over year.

As of its latest reported balance sheet, it holds $413.03M in cash and securities against $542.47M of debt, a net debt position of $129.44M.

uniQure does not currently pay a dividend.

The share price is down 61.0% over the past year. At $22.43 (the Oct 23, 2026 close) it sits within its 52-week range of $8.73 to $71.50, below its 200-day moving average of $29.62.

Based on 12 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $53.57, 138.8% above the Oct 23, 2026 close.

Frequently Asked Questions About uniQure

What is the current stock price for QURE?

As of the Oct 23, 2026 close, QURE stock trades at $22.43. The 52-week range is $8.73–$71.50, with a day range of $22.04–$23.28.

What is the P/E ratio for QURE?

The P/E ratio (Price-to-Earnings) for QURE is shown in the Key Statistics section. This valuation metric helps compare uniQure N.V. to industry peers.

Does QURE pay dividends?

uniQure does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.

What do analysts recommend for QURE?

Based on ratings from 12 professional analysts over the last 90 days, the consensus for QURE is Buy. The average 12-month price target is $53.57, a 138.8% upside from the Oct 23, 2026 close of $22.43.

What is the market cap of QURE?

As of the Oct 23, 2026 close, uniQure's market capitalization is $1.49B, classifying it as a small-cap company. uniQure operates in the Healthcare sector within the Biotechnology industry.